MARKET

CLRB

CLRB

Cellectar Biosciences Inc
NASDAQ
2.570
+0.100
+4.05%
After Hours: 2.520 -0.05 -1.95% 17:20 12/01 EST
OPEN
2.470
PREV CLOSE
2.470
HIGH
2.590
LOW
2.390
VOLUME
271.31K
TURNOVER
0
52 WEEK HIGH
3.150
52 WEEK LOW
1.250
MARKET CAP
31.58M
P/E (TTM)
-0.7480
1D
5D
1M
3M
1Y
5Y
Cellectar Biosciences Inc: Current report
Press release · 2d ago
Cellectar Biosciences Inc: Correspondence
Press release · 2d ago
Cellectar Biosciences Inc: [Cover]SEC-generated letter
Press release · 2d ago
Weekly Report: what happened at CLRB last week (1120-1124)?
Weekly Report · 4d ago
Weekly Report: what happened at CLRB last week (1113-1117)?
Weekly Report · 11/20 12:28
Cellectar Biosciences Inc: Quarterly report
Press release · 11/13 12:35
Weekly Report: what happened at CLRB last week (1106-1110)?
Weekly Report · 11/13 12:19
Weekly Report: what happened at CLRB last week (1030-1103)?
Weekly Report · 11/06 12:27
More
About CLRB
Cellectar Biosciences, Inc. is a late-stage clinical biopharmaceutical company. The Company is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The Company, through phospholipid ether drug conjugate (PDC) delivery platform, is focused on to develop PDCs that are designed to specifically target cancer cells. Its PDC platform possesses the potential for the discovery and development of cancer-targeting treatments, and it plans to develop PDCs both independently and through research and development collaborations. Its product pipeline includes iopofosine, a small-molecule PDC designed to provide targeted delivery of iodine-131 (radioisotope), preclinical PDC chemotherapeutic programs and multiple partnered PDC assets. It is also evaluating iopofosine in highly refractory multiple myeloma patients in its Phase 2 CLOVER-1 study and relapsed/refractory pediatric cancer patients with sarcomas or brain tumors in the Phase 1 CLOVER-2 study.

Webull offers Cellectar Biosciences Inc stock information, including NASDAQ: CLRB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CLRB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CLRB stock methods without spending real money on the virtual paper trading platform.